C. Owczarek

D. Hilton, M. Layton, C. Owczarek, 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure

C. Owczarek, S. Bozinovski, R. Vlahos, 2022, Respirology.

Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice.

C. Begley, M. Layton, C. Owczarek, 1996, The Journal of biological chemistry.

A Type I Interferon Signaling Factor, ISF21, Encoded on Chromosome 21 Is Distinct from Receptor Components and Their Down-regulation and Is Necessary for Transcriptional Activation of Interferon-regulated Genes*

M. Tymms, I. Kola, S. Constantinescu, 1997, The Journal of Biological Chemistry.

Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody.

M. Dottore, Angel F. Lopez, T. Nero, 2014, Cell reports.

Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies

S. Mahler, Nadya Panagides, C. Owczarek, 2022, International journal of molecular sciences.

Targeting the human βc receptor inhibits contact dermatitis in a transgenic mouse model.

Angel F. Lopez, H. Ramshaw, M. Maxwell, 2021, The Journal of investigative dermatology.

Identification and characterization of polymorphisms at the HSA α

J. Curtin, C. Owczarek, P. Board, 2002 .

A novel member of the STOMATIN/EPB72/mec-2 family, stomatin-like 2 (STOML2), is ubiquitously expressed and localizes to HSA chromosome 9p13.1

I. Kola, P. Hertzog, H. Treutlein, 2001, Cytogenetic and Genome Research.

Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics

P. Buehler, M. Pelzing, M. Hardy, 2018, BMC Biotechnology.

Cloning and Characterization of Soluble and Transmembrane Isoforms of a Novel Component of the Murine Type I Interferon Receptor, IFNAR 2*

I. Kola, S. Hwang, N. Reich, 1997, The Journal of Biological Chemistry.

Characterization and transcriptional analysis of the mouse Chromosome 16 cytokine receptor gene cluster

P. Hertzog, M. Hardy, E. Sanij, 2003, Mammalian Genome.

Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics.

P. Buehler, M. Hardy, F. Vallelian, 2021, Molecular pharmaceutics.

SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine

Paul J Hertzog, Donald Metcalf, Warren S Alexander, 1999, Cell.

Soluble IFN Receptor Potentiates In Vivo Type I IFN Signaling and Exacerbates TLR4-Mediated Septic Shock

S. Samarajiwa, P. Hertzog, M. Hardy, 2014, The Journal of Immunology.

The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.

I. Kola, P. Hertzog, M. Hardy, 2001, Blood.

Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16.

I. Kola, N. Shimizu, J. Kudoh, 2004, Gene.

Identification and Characterization of Two Distinct Truncated Forms of gp130 and a Soluble Form of Leukemia Inhibitory Factor Receptor α-Chain in Normal Human Urine and Plasma*

L. D. Ward, R. Moritz, K. Yasukawa, 1998, The Journal of Biological Chemistry.

EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE)

T. Kilpatrick, H. Butzkueven, L. Fabri, 2013, PloS one.

The Unusual Species Cross-reactivity of the Leukemia Inhibitory Factor Receptor α-Chain Is Determined Primarily by the Immunoglobulin-like Domain*

M. Layton, C. Owczarek, N. Nicola, 1997, The Journal of Biological Chemistry.

Role of the β Common (βc) Family of Cytokines in Health and Disease.

J. Sandow, Angel F. Lopez, P. Ekert, 2018, Cold Spring Harbor perspectives in biology.

TLR4-Mediated Septic Shock Type I IFN Signaling and Exacerbates Soluble IFN Receptor Potentiates In Vivo

S. Samarajiwa, P. Hertzog, C. Owczarek, 2014 .

Table of contents

K. Cusi, G. Su, M. Sugiyama, 2017 .

The primary transcription unit of the human alpha 2 globin gene defined by quantitative RT/PCR.

N. Proudfoot, C. Owczarek, P. Enriquez-Harris, 1992, Nucleic acids research.

Translating the biology of β common receptor-engaging cytokines into clinical medicine.

Angel F. Lopez, M. Parker, C. Owczarek, 2022, The Journal of allergy and clinical immunology.

Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression.

P. Hertzog, M. Hardy, C. Owczarek, 2002, The Biochemical journal.

Homology modelling and 1H NMR studies of human leukaemia inhibitory factor

D K Smith, R. Norton, M. Layton, 1994, FEBS letters.

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

Michael J. Wilson, M. Dottore, Angel F. Lopez, 2015, mAbs.

Inter‐species chimeras of leukaemia inhibitory factor define a major human receptor‐binding determinant.

M. Layton, T. Willson, C. Owczarek, 1993, The EMBO journal.

Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362.

Angel F. Lopez, T. Nero, M. Parker, 2014, Acta crystallographica. Section F, Structural biology communications.

A robust robotic high-throughput antibody purification platform.

L. Fabri, M. Hardy, P. Schmidt, 2016, Journal of chromatography. A.

Identification and characterization of polymorphisms at the HAS alpha1-acid glycoprotein (ORM*) gene locus in Caucasians.

C. Owczarek, P. Board, A. Owczarek, 2002, Genetics and molecular research : GMR.

Identification and characterization of polymorphisms at the HSA alpha1-acid glycoprotein (ORM*) gene locus in Caucasians

C. Owczarek, P. Board, A. Owczarek, 2002 .

Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution.

J. G. Zhang, L. D. Ward, L. Fabri, 1997, The Biochemical journal.

NMR studies of a murine-human chimera of leukaemia inhibitory factor (LIF). Comparison with human LIF.

J. G. Zhang, R. Norton, M. Layton, 1994, Growth factors.

Optimizing high throughput antibody purification by using continuous chromatography media.

L. Fabri, M. Hardy, P. Schmidt, 2019, Protein expression and purification.

Generation and characterization of recombinant unmodified and phosphorylatable murine IFN-alpha1 in the methylotropic yeast Pichia pastoris.

P. Hertzog, C. Owczarek, P. Stanton, 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer

L. Fabri, B. Forbes, M. Hardy, 2014, British Journal of Cancer.

Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.

Adriana Baz Morelli, S. Dower, M. Hardy, 2022, The Biochemical journal.

Role of the beta Common (beta c) Family of Cytokines in Health and Disease

J. Sandow, Angel F. Lopez, P. Ekert, 2018 .

Ethnicity, deprivation and screening: survival from breast cancer among screening-eligible women in the West Midlands diagnosed from 1989 to 2011

B. Rachet, D. Nicol, D. Fitzpatrick, 2015, British Journal of Cancer.